id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0003-0081,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 141-324 Phenylpropanolamine,Supporting & Related Material,Freedom of Information Summary,2012-03-19T04:00:00Z,2012,3,,,2012-03-19T19:03:24Z,,0,0,0900006480fdb2bc
FDA-2011-N-0003-0080,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 141-331 Pergolide,Supporting & Related Material,Freedom of Information Summary,2012-03-19T04:00:00Z,2012,3,,,2012-03-19T16:43:41Z,,0,0,0900006480fda89d
FDA-2011-N-0003-0079,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Phenylpropanolamine,Rule,Final Rule,2012-03-19T04:00:00Z,2012,3,2012-03-19T04:00:00Z,,2012-03-19T16:36:30Z,2012-06553,0,0,0900006480fdac8f
FDA-2011-N-0003-0078,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Pergolide,Rule,Final Rule,2012-03-19T04:00:00Z,2012,3,2012-03-19T04:00:00Z,,2012-03-19T13:39:39Z,2012-06544,0,0,0900006480fdac97
FDA-2011-N-0003-0077,FDA,FDA-2011-N-0003,"Animal Drugs, Feeds, and Related Products: N-Methyl-2-Pyrrolidone; Correction",Rule,Correction,2012-02-17T05:00:00Z,2012,2,2012-02-17T05:00:00Z,,2012-02-17T14:12:13Z,2012-03747,0,0,0900006480fb8faf
FDA-2011-N-0003-0076,FDA,FDA-2011-N-0003,FDA/DDM Courtesy Letter to the Holders of Applications - Letter,Other,Letter(s),2012-02-16T05:00:00Z,2012,2,2012-02-16T05:00:00Z,,2012-02-16T23:45:05Z,,0,0,0900006480fac666
FDA-2011-N-0003-0075,FDA,FDA-2011-N-0003,New Animal Drugs: Change of Sponsor; Chlortetracycline Powder,Rule,,2012-02-06T05:00:00Z,2012,2,2012-02-06T05:00:00Z,,2012-02-06T17:48:19Z,2012-02633,0,0,0900006480fae382
FDA-2011-N-0003-0073,FDA,FDA-2011-N-0003,"New Animal Drugs: Chloramphenicol, Diethylcarbamazine Citrate, Hygromycin B, Methoxyflurane, Neomycin Sulfate, Penicillin G, Phenylbutazone,etc.",Rule,Final Rule,2012-02-01T05:00:00Z,2012,2,2012-02-01T05:00:00Z,,2012-02-01T15:16:51Z,2012-02103,0,0,0900006480faacf8
FDA-2011-N-0003-0074,FDA,FDA-2011-N-0003,Withdrawal of Approval of New Animal Drug Applications,Notice,General Notice,2012-02-01T05:00:00Z,2012,2,2012-02-01T05:00:00Z,,2012-02-01T15:47:20Z,2012-02109,0,0,0900006480faacba
FDA-2011-N-0003-0063,FDA,FDA-2011-N-0003,Freedom of Information Summary ANDA 200-494 - Gentamicin Sulfate,Supporting & Related Material,Freedom of Information Summary,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:18:17Z,,0,0,0900006480fa722e
FDA-2011-N-0003-0067,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 141-207 - Danofloxacin,Supporting & Related Material,Freedom of Information Summary,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:33:04Z,,0,0,0900006480fa7232
FDA-2011-N-0003-0062,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Gentamicin Sulfate,Rule,Final Rule,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:11:48Z,2012-01753,0,0,0900006480fa6f59
FDA-2011-N-0003-0065,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 141-322 - Gonadotropin Releasing Factor Analog-Diphtheria Toxoid Conjugate,Supporting & Related Material,Freedom of Information Summary,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:24:50Z,,0,0,0900006480fa7230
FDA-2011-N-0003-0069,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 095-735 - Monensin,Supporting & Related Material,Freedom of Information Summary,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T15:00:40Z,,0,0,0900006480fa729f
FDA-2011-N-0003-0071,FDA,FDA-2011-N-0003,"Oral Dosage Form New Animal Drugs: Milbemycin Oxime, Lufenuron, and Praziquantel",Rule,Final Rule,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T15:09:20Z,2012-01744,0,0,0900006480fa7022
FDA-2011-N-0003-0064,FDA,FDA-2011-N-0003,Implantation or Injectable Dosage Form New Animal Drugs: Gonadotropin Releasing Factor Analog-Diphtheria Toxoid Conjugate,Rule,Final Rule,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:20:52Z,2012-01754,0,0,0900006480fa6f61
FDA-2011-N-0003-0072,FDA,FDA-2011-N-0003,"Freedom of Information Summary NADA 141-333 - Milbemycin Oxime, Lufenuron, and Praziquantel",Supporting & Related Material,Reference (internal unless indicated),2012-01-27T05:00:00Z,2012,1,,,2012-01-27T15:12:54Z,,0,0,0900006480fa72a3
FDA-2011-N-0003-0068,FDA,FDA-2011-N-0003,New Animal Drugs for Use in Animal Feeds: Monensin,Rule,Final Rule,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:56:44Z,2012-01755,0,0,0900006480fa6ff0
FDA-2011-N-0003-0070,FDA,FDA-2011-N-0003,New Animal Drugs: Change of Sponsor's Name,Rule,Final Rule,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T15:05:48Z,2012-01756,0,0,0900006480fa6ff4
FDA-2011-N-0003-0066,FDA,FDA-2011-N-0003,Implantation or Injectable Dosage Form New Animal Drugs: Danofloxacin,Rule,Final Rule,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:27:44Z,2012-01743,0,0,0900006480fa6f98
FDA-2011-N-0003-0061,FDA,FDA-2011-N-0003,reedom of Information Summary NADA 141-203 Deracoxib,Supporting & Related Material,Freedom of Information Summary,2012-01-26T05:00:00Z,2012,1,,,2012-01-26T14:22:22Z,,0,0,0900006480fa50c0
FDA-2011-N-0003-0060,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Deracoxib,Rule,Final Rule,2012-01-26T05:00:00Z,2012,1,,,2012-01-26T14:09:02Z,2012-01622,0,0,0900006480fa5564
FDA-2011-N-0003-0058,FDA,FDA-2011-N-0003,Ophthalmic and Topical Dosage Form New Animal Drugs: Gentamicin and Betamethasone Spray,Rule,Final Rule,2012-01-25T05:00:00Z,2012,1,2012-01-25T05:00:00Z,,2012-01-25T21:11:07Z,2012-01501,0,0,0900006480fa3c14
FDA-2011-N-0003-0059,FDA,FDA-2011-N-0003,"Gentamicin Topical Spray (gentamicin sulfate, betamethasone valerate- ANADA 200-416; Freedom of Information Summary",Supporting & Related Material,Freedom of Information Summary,2012-01-25T05:00:00Z,2012,1,,,2012-01-25T21:52:45Z,,0,0,0900006480fa4961
FDA-2011-N-0003-0057,FDA,FDA-2011-N-0003,Freedom of Information Summary ANDA 200-318 Bimectin Pour-On (Ivermectin),Supporting & Related Material,Reference (internal unless indicated),2011-12-29T05:00:00Z,2011,12,,,2011-12-29T14:03:11Z,,0,0,0900006480f8ad17
FDA-2011-N-0003-0056,FDA,FDA-2011-N-0003,Ophthalmic and Topical Dosage Form New Animal Drugs: Ivermectin Topical Solution,Rule,Final Rule,2011-12-29T05:00:00Z,2011,12,2011-12-29T05:00:00Z,,2011-12-29T13:58:17Z,2011-33382,0,0,0900006480f8acdf
FDA-2011-N-0003-0054,FDA,FDA-2011-N-0003,New Animal Drugs for Use in Animal Feeds: Monensin,Rule,Final Rule,2011-12-21T05:00:00Z,2011,12,2011-12-21T05:00:00Z,,2011-12-21T22:06:14Z,2011-32427,0,0,0900006480f87099
FDA-2011-N-0003-0055,FDA,FDA-2011-N-0003,New Animal Drugs: Change of Sponsor; Zinc Gluconate,Rule,Final Rule,2011-12-21T05:00:00Z,2011,12,2011-12-21T05:00:00Z,,2011-12-21T22:32:43Z,2011-32591,0,0,0900006480f87170
FDA-2011-N-0003-0052,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Cyclosporine,Rule,Final Rule,2011-12-20T05:00:00Z,2011,12,2011-12-20T05:00:00Z,,2011-12-20T15:34:59Z,2011-32526,0,0,0900006480f864a7
FDA-2011-N-0003-0053,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 141-329 Cyclosporine,Supporting & Related Material,Freedom of Information Summary,2011-12-20T05:00:00Z,2011,12,,,2011-12-20T17:17:34Z,,0,0,0900006480f86905
FDA-2011-N-0003-0049,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 141-325 Incurin (Estriol),Supporting & Related Material,Freedom of Information Summary,2011-12-16T05:00:00Z,2011,12,,,2011-12-16T18:43:16Z,,0,0,0900006480f843e3
FDA-2011-N-0003-0048,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Estriol,Rule,Final Rule,2011-12-16T05:00:00Z,2011,12,2011-12-16T05:00:00Z,,2011-12-16T18:28:06Z,2011-32214,0,0,0900006480f84681
FDA-2011-N-0003-0050,FDA,FDA-2011-N-0003,"Ophthalmic and Topical Dosage Form New Animal Drugs: Hydrocortisone Aceponate, Miconazole Nitrate, and Gentamicin Sulfate Otic Suspension",Rule,Final Rule,2011-12-16T05:00:00Z,2011,12,2011-12-16T05:00:00Z,,2011-12-16T19:26:27Z,2011-32226,0,0,0900006480f846b9
FDA-2011-N-0003-0051,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 141-330 EASOTIC,Supporting & Related Material,Freedom of Information Summary,2011-12-16T05:00:00Z,2011,12,,,2011-12-20T17:21:00Z,,0,0,0900006480f844a8
FDA-2011-N-0003-0045,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 141-064 Pulmotil 90 Tilmicosin,Supporting & Related Material,Reference (internal unless indicated),2011-12-09T05:00:00Z,2011,12,,,2011-12-09T18:12:30Z,,0,0,0900006480f7f1b7
FDA-2011-N-0003-0046,FDA,FDA-2011-N-0003,Enviromental Risk Assessment NADA 141-064,Supporting & Related Material,Reference (internal unless indicated),2011-12-09T05:00:00Z,2011,12,,,2011-12-09T18:16:50Z,,0,0,0900006480f7f1b9
FDA-2011-N-0003-0044,FDA,FDA-2011-N-0003,New Animal Drugs for Use in AnimalFeeds: Tilmicosin,Rule,Final Rule,2011-12-09T05:00:00Z,2011,12,,,2011-12-09T16:06:45Z,2011-31613,0,0,0900006480f7edc7
FDA-2011-N-0003-0047,FDA,FDA-2011-N-0003,Finding of No Significant Impact (FONSI) - NADA 141-064,Supporting & Related Material,Reference (internal unless indicated),2011-12-09T05:00:00Z,2011,12,,,2011-12-09T18:21:05Z,,0,0,0900006480f7f1bd
FDA-2011-N-0003-0043,FDA,FDA-2011-N-0003,Eprinomectin Extended- Release Injectable Parasiticide for Cattle NADA 141-327 - Environmental Impact Assessment,Supporting & Related Material,Environmental Assessment,2011-12-06T05:00:00Z,2011,12,,,2011-12-06T21:48:41Z,,0,0,0900006480f7c8c5
FDA-2011-N-0003-0042,FDA,FDA-2011-N-0003,Eprinomectin Extended- Release Injectable Parasiticide for Cattle  NADA 141-327- Finding of no Significant Impact,Supporting & Related Material,Finding of no Significant Impact,2011-12-06T05:00:00Z,2011,12,,,2011-12-06T21:39:57Z,,0,0,0900006480f7c8c4
FDA-2011-N-0003-0041,FDA,FDA-2011-N-0003,LONGRANGE (eprinomectin) Extended- Release Injectable Parasiticide NADA 141-327- Freedom of Information Summary,Supporting & Related Material,Freedom of Information Summary,2011-12-05T05:00:00Z,2011,12,,,2011-12-05T16:17:41Z,,0,0,0900006480f7a085
FDA-2011-N-0003-0040,FDA,FDA-2011-N-0003,Ophthalmic and Topical Dosage Form New Animal Drugs; Eprinomectin,Rule,Final Rule,2011-11-25T05:00:00Z,2011,11,2011-11-25T05:00:00Z,,2011-11-25T14:20:46Z,2011-30328,0,0,0900006480f73670
FDA-2011-N-0003-0039,FDA,FDA-2011-N-0003,"Animal Drugs, Feeds, and Related Products; Eprinomectin; N-Methyl-2-Pyrrolidone",Rule,Final Rule,2011-11-25T05:00:00Z,2011,11,,,2011-11-25T14:23:01Z,2011-30329,0,0,0900006480f73650
FDA-2011-N-0003-0037,FDA,FDA-2011-N-0003,New Animal Drugs for Use in Animal Feeds: Melengestrol; Monensin; Tylosin,Rule,Final Rule,2011-10-20T04:00:00Z,2011,10,2011-10-20T04:00:00Z,,2011-10-20T14:02:09Z,2011-27139,0,0,0900006480f56b31
FDA-2011-N-0003-0038,FDA,FDA-2011-N-0003,Heifermax 500 Plus Rumensin and Tylan (melengestrol acetate plus monensin and tylosin phosphate) ANDA 200-375 - Freedom of Information Summary,Supporting & Related Material,Freedom of Information Summary,2011-10-20T04:00:00Z,2011,10,,,2011-12-05T17:13:59Z,,0,0,0900006480f56c9a
FDA-2011-N-0003-0035,FDA,FDA-2011-N-0003,New Animal Drugs for Use in Animal Feeds: Melengestrol; Monensin,Rule,Final Rule,2011-09-30T04:00:00Z,2011,9,2011-09-30T04:00:00Z,,2011-09-30T13:05:07Z,2011-25220,0,0,0900006480f45b6a
FDA-2011-N-0003-0036,FDA,FDA-2011-N-0003,Freedom of Information Summary ANDA 200-422 Heifermax 500 plus  Rumensin,Other,Freedom of Information Summary (No Federal Register Publication),2011-09-30T04:00:00Z,2011,9,2011-09-30T04:00:00Z,,2011-09-30T13:13:51Z,,0,0,0900006480f4344f
FDA-2011-N-0003-0034,FDA,FDA-2011-N-0003,Tylomed-WS  (tylosin tartrate soluble powder) ANDA 200-455 - Freedom of Information Summary,Supporting & Related Material,Freedom of Information Summary,2011-09-23T04:00:00Z,2011,9,,,2011-12-05T17:16:18Z,,0,0,0900006480f28610
FDA-2011-N-0003-0033,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Tylosin,Rule,Final Rule,2011-09-23T04:00:00Z,2011,9,2011-09-23T04:00:00Z,,2011-09-23T13:49:15Z,2011-24461,0,0,0900006480f28536
FDA-2011-N-0003-0031,FDA,FDA-2011-N-0003,New Animal Drugs: Gamithromycin,Rule,Final Rule,2011-09-19T04:00:00Z,2011,9,2011-09-19T04:00:00Z,,2011-09-19T16:38:18Z,2011-23874,0,0,0900006480f22065
FDA-2011-N-0003-0030,FDA,FDA-2011-N-0003,Tolerances for Residues of New Animal Drugs in Food: Progesterone,Rule,Final Rule,2011-09-19T04:00:00Z,2011,9,2011-09-19T04:00:00Z,,2011-09-19T16:31:42Z,2011-23867,0,0,0900006480f220a7
FDA-2011-N-0003-0032,FDA,FDA-2011-N-0003,Zactran (gamithomycin injectable solution) (NADA 141-328) - Freedom of Information Summary,Supporting & Related Material,Freedom of Information Summary,2011-09-19T04:00:00Z,2011,9,,,2011-12-05T17:18:47Z,,0,0,0900006480f227f4
FDA-2011-N-0003-0028,FDA,FDA-2011-N-0003,Implantation or Injectable Dosage Form New Animal Drugs: Ivermectin,Rule,Final Rule,2011-09-19T04:00:00Z,2011,9,2011-09-19T04:00:00Z,,2011-09-19T16:03:53Z,2011-23865,0,0,0900006480f22114
FDA-2011-N-0003-0029,FDA,FDA-2011-N-0003,Bimectin Injectable Solution (ivermectin) (ANADA 200-447) - Freedom of Information Summary,Supporting & Related Material,Freedom of Information Summary,2011-09-19T04:00:00Z,2011,9,,,2011-12-05T17:20:22Z,,0,0,0900006480f22608
FDA-2011-N-0003-0027,FDA,FDA-2011-N-0003,"New Animal Drugs: Ampicillin Trihydrate, Bacitracin Methylene Disalicylate, Flunixin, etc.; Correcting Amendments",Rule,Correction,2011-08-25T04:00:00Z,2011,8,,,2011-08-25T13:40:34Z,2011-21721,0,0,0900006480eee4b8
FDA-2011-N-0003-0026,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Change of Sponsor; Chlortetracycline; Sulfamethazine,Rule,Final Rule,2011-08-11T04:00:00Z,2011,8,,,2011-08-11T13:46:29Z,2011-20404,0,0,0900006480edde3b
FDA-2011-N-0003-0025,FDA,FDA-2011-N-0003,New Animal Drugs: Change of Sponsor; Moxidectin,Rule,Final Rule,2011-08-09T04:00:00Z,2011,8,2011-08-09T04:00:00Z,,2011-08-09T14:46:08Z,2011-20182,0,0,0900006480edbacf
FDA-2011-N-0003-0023,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Amprolium,Rule,Final Rule,2011-07-12T04:00:00Z,2011,7,2011-07-12T04:00:00Z,,2011-07-12T14:34:01Z,2011-17465,0,0,0900006480ec062c
FDA-2011-N-0003-0024,FDA,FDA-2011-N-0003,Ampromed P (amprolium) (ANADA 200-488) -  Freedom of Information Summary,Supporting & Related Material,Freedom of Information Summary,2011-07-12T04:00:00Z,2011,7,,,2011-12-05T17:21:57Z,,0,0,0900006480ec0a71
FDA-2011-N-0003-0022,FDA,FDA-2011-N-0003,New Animal Drugs: Change of Sponsor's Name and Address,Rule,Final Rule,2011-07-11T04:00:00Z,2011,7,2011-07-11T04:00:00Z,,2011-07-11T13:50:45Z,2011-17292,0,0,0900006480ebef6a
FDA-2011-N-0003-0021,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs; Change of Sponsor,Rule,Final Rule,2011-07-08T04:00:00Z,2011,7,2011-07-08T04:00:00Z,,2011-07-08T19:06:59Z,2011-17151,0,0,0900006480ebcfab
FDA-2011-N-0003-0020,FDA,FDA-2011-N-0003,New Animal Drugs: Change of Sponsor's Address,Rule,Final Rule,2011-07-06T04:00:00Z,2011,7,2011-07-06T04:00:00Z,,2011-07-06T18:50:24Z,2011-16845,0,0,0900006480eba135
FDA-2011-N-0003-0019,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Amprolium,Rule,Final Rule,2011-07-01T04:00:00Z,2011,7,2011-07-01T04:00:00Z,,2011-07-01T14:40:14Z,2011-16501,0,0,0900006480eb82fd
FDA-2011-N-0003-0017,FDA,FDA-2011-N-0003,Implantation or Injectable Dosage Form New Animal Drugs: Gonadotropin Releasing Factor-Diphtheria Toxoid Conjugate,Rule,NFR-Notice of Final Rule,2011-05-13T04:00:00Z,2011,5,2011-05-13T04:00:00Z,,2011-05-13T12:55:58Z,2011-11762,0,0,0900006480c79e08
FDA-2011-N-0003-0018,FDA,FDA-2011-N-0003,Freedom Of Information Summary - [NADA 141-322],Supporting & Related Material,FOIS-Freedom of Information Summary,2011-05-13T04:00:00Z,2011,5,,,2011-05-13T13:04:01Z,,0,0,0900006480c79711
FDA-2011-N-0003-0015,FDA,FDA-2011-N-0003,Implantation or Injectable Dosage Form New Animal Drugs: Enrofloxacin,Rule,NFR-Notice of Final Rule,2011-04-22T04:00:00Z,2011,4,2011-04-22T04:00:00Z,,2011-04-22T13:02:12Z,2011-09765,0,0,0900006480c35d41
FDA-2011-N-0003-0016,FDA,FDA-2011-N-0003,Freedom Of Information Summary [ NADA 141-068],Supporting & Related Material,FOIS-Freedom of Information Summary,2011-04-22T04:00:00Z,2011,4,,,2011-04-22T13:13:04Z,,0,0,0900006480c35ae1
FDA-2011-N-0003-0013,FDA,FDA-2011-N-0003,Attachment - Veterinary insert for Product carton - [Freedom Of Information Summary - NADA 141-320 [ONSIOR Robenacoxib Tablets Cats],Supporting & Related Material,FOIS-Freedom of Information Summary,2011-04-20T04:00:00Z,2011,4,,,2011-04-20T17:24:19Z,,0,0,0900006480c33a6c
FDA-2011-N-0003-0014,FDA,FDA-2011-N-0003,Attachment - Owner insert for dispensing envelope - [Freedom Of Information Summary - NADA 141-320 [ONSIOR Robenacoxib Tablets Cats],Supporting & Related Material,FOIS-Freedom of Information Summary,2011-04-20T04:00:00Z,2011,4,,,2011-04-20T17:28:01Z,,0,0,0900006480c33a9b
FDA-2011-N-0003-0012,FDA,FDA-2011-N-0003,Freedom Of Information Summary - NADA 141-320 [ONSIOR Robenacoxib Tablets Cats],Supporting & Related Material,FOIS-Freedom of Information Summary,2011-04-05T04:00:00Z,2011,4,,,2011-04-05T14:04:47Z,,0,0,0900006480c1b79a
FDA-2011-N-0003-0011,FDA,FDA-2011-N-0003,Oral Dosages Form New Animal Drugs: Robenacoxib,Rule,NFR-Notice of Final Rule,2011-04-05T04:00:00Z,2011,4,2011-04-05T04:00:00Z,,2011-04-05T13:54:22Z,2011-08053,0,0,0900006480c1bc56
FDA-2011-N-0003-0009,FDA,FDA-2011-N-0003,"New Animal Drugs: Amikacin Sulfate, Ampicillin Trihydrate, Ceftiofur Hydrochloride, Cephapirin Benzathine, etc.; Correcting Amendments",Rule,NCR-Notice of Correction,2011-03-29T04:00:00Z,2011,3,2011-03-29T04:00:00Z,,2011-03-29T13:29:20Z,2011-07313,0,0,0900006480c1279e
FDA-2011-N-0003-0010,FDA,FDA-2011-N-0003,Freedom Of Information Summary - 200-026 [PENNOX 343],Supporting & Related Material,FOIS-Freedom of Information Summary,2011-03-29T04:00:00Z,2011,3,,,2011-03-29T13:44:53Z,,0,0,0900006480c12b4e
FDA-2011-N-0003-0007,FDA,FDA-2011-N-0003,New Animal Drugs: Oxytetracycline,Rule,NFR-Notice of Final Rule,2011-03-28T04:00:00Z,2011,3,2011-03-28T04:00:00Z,,2011-03-28T14:44:26Z,2011-07216,0,0,0900006480c11e79
FDA-2011-N-0003-0008,FDA,FDA-2011-N-0003,New Animal Drugs: Arsanilate Sodium; Sulfaethoxypyridazine,Rule,NFR-Notice of Final Rule,2011-03-28T04:00:00Z,2011,3,2011-03-28T04:00:00Z,,2011-03-28T14:56:22Z,2011-07214,0,0,0900006480c11e7a
FDA-2011-N-0003-0006,FDA,FDA-2011-N-0003,"Tolerances for Residues of New Animal Drugs in Food: 2-Acetylamino-5-Nitrothiazole; Buquinolate; Chlorobutanol; Estradiol and Related Esters, etc.; Correcting Amendments",Rule,NFR-Notice of Final Rule,2011-03-25T04:00:00Z,2011,3,2011-03-25T04:00:00Z,,2011-03-25T15:07:49Z,2011-06796,0,0,0900006480c10d09
FDA-2011-N-0003-0004,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Spinosad and Milbemycin Oxime,Rule,NFR-Notice of Final Rule,2011-03-08T05:00:00Z,2011,3,2011-03-08T05:00:00Z,,2011-03-08T16:02:16Z,2011-05144,0,0,0900006480c0323d
FDA-2011-N-0003-0005,FDA,FDA-2011-N-0003,Freedom Of Information Summary- 141-321 [TRIFEXIS Spinosad and Milbemycin oxime Chewable Tablets Dogs],Supporting & Related Material,FOIS-Freedom of Information Summary,2011-03-08T05:00:00Z,2011,3,,,2011-03-08T16:19:23Z,,0,0,0900006480c02cd8
FDA-2011-N-0003-0003,FDA,FDA-2011-N-0003,"Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications: Phenylbutazone; Pyrantel; Tylosin",Notice,NFR-Notice of Final Rule,2011-03-02T05:00:00Z,2011,3,,,2011-03-02T17:54:11Z,2011-04546,0,0,0900006480bfcca3
FDA-2011-N-0003-0001,FDA,FDA-2011-N-0003,New Animal Drugs: Masitinib,Rule,NFR-Notice of Final Rule,2011-02-04T05:00:00Z,2011,2,2011-02-04T05:00:00Z,,2011-02-04T15:32:40Z,2011-2519,0,0,0900006480bdbad8